The US Food and Drug Administration (FDA) has approved Celltrion’s aflibercept-boav (EYDENZELT) biosimilar referencing ...
Considering this knowledge of the retina, the investigators conducted a study in which the goals were to detect and quantify ...
REGENXBIO completed enrollment in its ATMOSPHERE and ASCENT trials that will be evaluating surabgene lomparvovec (sura-vec, ...
Early and aggressive treatment of dry eye disease can prevent progression and preserve ocular health, especially in glaucoma ...
The jump from training to independent practice is a uniquely personal experience. For some, it feels like a natural next step ...
The tension between STAAR and Broadwood Partners continues as both have issued further statements for and against the ...
Privosegtor (also known as OCS-05) is a “first-in-class peptoid small molecule” for neuroprotective therapy for acute optic ...
The AAOP's new training platform, developed with Alchemy Vision, enhances practice efficiency and patient care through video-driven education for ophthalmic technicians and clinical team members.
The YOURS Committee supports young retina specialists with educational initiatives, professional development, and networking ...
High-resolution OCT identifies significant retinal changes in PXE, particularly in calcified regions, aiding future ...
Study finds retinal progenitor cell injections improve outcomes in rat model of diabetic retinopathy
Intravitreal RPCs showed positive effects on electroretinography, optomotor response, and contrast sensitivity in a rat model ...
MK-3000, a tri-specific antibody, is being tested in the BRUNELLO trial for diabetic macular edema, following positive ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback